News, Policy & Media

24May

Government response to report on Brexit and medicines, medical devices and substances of human origin

Command paper responding to the Health and Social Care Committee's report 'Brexit: medicines, medical devices and substances of human origin'.

Published 23 May 2018
From:
Department of Health and Social Care, Intellectual Property Office, Medicines and Healthcare products Regulatory Agency, Office for Life Sciences, and Department for Exiting the European Union
Documents

Brexit: medicines, medical devices and substances of human origin – government response to the Health and Social Care Committee's 4th report of session 2017 to 2019
 

Details
This command paper sets out the government’s response to the Health and Social Care Committee’s report following their inquiry into Brexit: medicines, medical devices and substances of human origin.

The committee published their report on 21 March 2018.

This response was prepared by the Department of Health and Social Care, in collaboration with other government departments and agencies including:

the Medicines and Healthcare products Regulatory Agency
the Office for Life Sciences
the Intellectual Property Office
the Department for Exiting the European Union
Published 23 May 2018

Related

Ninth annual report analysing the updated 2017 dataset from the bioscience and health technologies d...

Read More >

Members can find attached a short briefing note outlining the Medicines and Medical Devices Bill whi...

Read More >

Please see below a Dear Colleague letter from the Office of Life Sciences Dear colleague, ...

Read More >

BIVDA attended an update with DHSC today, and a couple of points of note were made which may be usef...

Read More >

The University of Liverpool has launched a new service to improve Research and Development access am...

Read More >

An update has been issued on the Medicines and Medical Devices Bill’s journey through Parliame...

Read More >